Litigation Details for Horizon Therapeutics, LLC v. Par Pharmaceuticals, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Horizon Therapeutics, LLC v. Par Pharmaceuticals, Inc. (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-08-10 |
| Court | District Court, D. Delaware | Date Terminated | 2018-10-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 8,642,012 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Horizon Therapeutics, LLC v. Par Pharmaceuticals, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Horizon Therapeutics, LLC v. Par Pharmaceuticals, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-08-10 | 1 | Complaint | States Patent No. 8,642,012 (“the ’012 patent”). A true and accurate copy of the ’012 patent is attached… U.S. PATENT NO. 8,642,012 1. On February 4, 2014, the U.S. Patent and Trademark … 1. This is an action for patent infringement under the patent laws of the United States, Title… As owner of the ’012 patent, Horizon is authorized to enforce the ’012 patent. …which are claimed in the ’012 patent—before the expiration of the ’012 patent. 32. Upon information | External link to document |
| 2018-10-02 | 27 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,642,012. (Attachments: # 1 …2018 2 October 2018 1:18-cv-01224 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2018-08-10 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,642,012. (crb) (Entered: 08…2018 2 October 2018 1:18-cv-01224 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
